Vivos Leadership Spotlight: Kelly McCrann

We have recently been spotlighting some of the members of the leadership team for Vivos Therapeutics. This next spotlight will look at Kelly McCrann who serves as one of the Directors to our Board of Directors. McCrann is currently a senior healthcare executive with extensive experience in board governance, strategic leadership, profit and loss management and strategic transactions. He also serves as the Chief Executive Officer of EyeCare Partners, LLC., which is a company that acquires and manages private medical ophthalmology and optometry practices.

McCrann joined our Board of Director after enjoying a 35-year career where he operated a broad range of healthcare companies. Some of his accolades include serving as the CEO of Advoserv, Crescent Healthcare, PacifiCare Dental & Vision, DaVita Home Dialysis and Professional Dental Associates. McCrann also worked for Coram Healthcare Corporation, HMSS, Inc., and Tenet Healthcare.

Now, prior to his operating career, McCrann received his B.A from the University of California, Los Angeles and his M.B.A from Harvard University. He also worked for McKinsey & Co. which is an internationally recognized business consulting firm. He currently serves on the Board of Directors of Lightwave Dental.

Kelly McCrann brings a wealth of knowledge and experience to his role as Director of our Board of Directors. His experience will certainly help Vivos in achieving its mission of combining new breakthrough technology to design oral appliances and proprietary clinical protocols to treat obstructive sleep apnea. We, at Vivos Therapeutics, are confident in McCrann’s abilities to provide the kind of innovation and knowledge needed to help us strive forward as we look to be the leader in sleep apnea treatment.

We are proud to welcome Kelly McCrann to our Board of Directors, and we look forward to his future contributions to help further improve the company. Be on the lookout for more company leadership spotlights and for more information about Vivos Therapeutics; please visit